17 December 2020
- RSIS
- Media Mentions
- Why is Asia Divided on a Green Light for Medical Marijuana?
Why is Asia Divided on a Green Light for Medical Marijuana?
The issue of cannabis legalisation around the world was once again thrust into the spotlight this month, following a vote by the UN Commission on Narcotic Drugs to reclassify it one that is less dangerous and has medical or therapeutic benefits. Faizal Abdul Rahman, a Research Fellow at Singapore’s RSIS, said if like-minded countries who opposed the UN vote wanted to object further, they could rally minilateral efforts in law enforcement cooperation and information exchanges to monitor how the reclassification would affect the global trade in narcotic drugs. They could also cooperate to understand how the UN development would affect public sentiment on drugs and devise better messaging to discourage lackadaisical attitudes about substance abuse.
CENS / Online / Print
Last updated on 18/12/2020
